Our study focuses uniquely on mechanisms leading to altered IRS2 expression in the liver of individuals with diabetes, as compared with non-diabetic participants, independent of classical risk factors, such as age, sex and obesity. This evidence concerns the gene IRS2 and obesity disorder.